150 related articles for article (PubMed ID: 7370988)
21. Circadian dependence of host and tumor responses to cyclophosphamide in mice.
Cardoso SS; Avery T; Venditti JM; Goldin A
Eur J Cancer (1965); 1978 Sep; 14(9):949-54. PubMed ID: 710487
[No Abstract] [Full Text] [Related]
22. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
[TBL] [Abstract][Full Text] [Related]
23. Combined effect of cytostatic drugs and E-N-L-trimethyl lysine in healthy and transplantable tumor bearing mice.
Szende B; Lapis K; Simon K
Neoplasma; 1982; 29(4):427-39. PubMed ID: 6813749
[TBL] [Abstract][Full Text] [Related]
24. Combined therapy of L1210 leukemia with Damvar and cytostatics.
Pujman V; Cernochová S
Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
[TBL] [Abstract][Full Text] [Related]
26. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
Góra-Tybor J; Robak T; Warzocha K; Grieb P
Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
[TBL] [Abstract][Full Text] [Related]
27. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
Razek A; Vietti T; Valeriote F
Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
[No Abstract] [Full Text] [Related]
28. Morphological changes in organs of mice induced by the combination of adriamycin and pustulan.
Fiszer-Maliszewska L; Mordarski M; Madej JA; Kotz J
Arch Immunol Ther Exp (Warsz); 1983; 31(3):365-72. PubMed ID: 6651486
[TBL] [Abstract][Full Text] [Related]
29. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
[TBL] [Abstract][Full Text] [Related]
30. Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
Tobias JS; Parker LM; Tattersall MH; Frei E
Br J Cancer; 1975 Aug; 32(2):199-207. PubMed ID: 1212350
[TBL] [Abstract][Full Text] [Related]
31. Chronobiology as it relates to toxicology, pharmacology, and chemotherapy.
Scheving LE; Scheving LA; Feuers RJ; Tsai TH; Cope FO
Regul Toxicol Pharmacol; 1993 Apr; 17(2 Pt 1):209-18. PubMed ID: 8484028
[TBL] [Abstract][Full Text] [Related]
32. [Synergistic effect of nucleoside and cyclophosphamide combination in murine L 1210 leukemia].
Drings P; Osswald H
Verh Dtsch Ges Inn Med; 1975; 81():1109-11. PubMed ID: 1229409
[No Abstract] [Full Text] [Related]
33. Chronomodulatory effect of cyclosporine upon survival of DBA mice with L1210 leukemia.
Sánchez de la Peña S; Halberg E; Halberg F; Sánchez E; Cornélissen G
Chronobiologia; 1986; 13(2):129-35. PubMed ID: 3731947
[TBL] [Abstract][Full Text] [Related]
34. [Combination chemotherapy of experimental leukemia].
Emanuel' NM; Konovalova NP; D'iachkovskaia RF
Vopr Onkol; 1977; 23(5):62-6. PubMed ID: 888420
[TBL] [Abstract][Full Text] [Related]
35. Combined therapy of mice bearing L1210 leukemia with adriamycin and mycobacteria.
Fiszer L; Mordarski M
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):873-9. PubMed ID: 749836
[TBL] [Abstract][Full Text] [Related]
36. On methods for testing and achieving cancer chronotherapy.
Halberg F; Nelson W; Cornelissen G; Haus E; Scheving LE; Good RA
Cancer Treat Rep; 1979 Aug; 63(8):1428-30. PubMed ID: 476717
[No Abstract] [Full Text] [Related]
37. Improved therapeutic index of cisplatin analogue: B-85-0040 by circadian timing.
von Roemeling R; Portuese E; Salzer M; Solis O; Bennett J; Sothern R; Hoffmann D; Sedlacek H
Prog Clin Biol Res; 1990; 341A():11-20. PubMed ID: 2217224
[TBL] [Abstract][Full Text] [Related]
38. The effect of the sequence of administration of cytoxan and methotrexate on the life-span of L1210 leukemic mice.
Straus MJ; Mantel N; Goldin A
Cancer Res; 1972 Feb; 32(2):200-7. PubMed ID: 5058180
[No Abstract] [Full Text] [Related]
39. Evaluation of combination chemotherapy with three drugs.
Goldin A; Venditti JM; Mantel N; Kline I; Gang M
Cancer Res; 1968 May; 28(5):950-60. PubMed ID: 5652309
[No Abstract] [Full Text] [Related]
40. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
Shiraga E; Barichello JM; Ishida T; Kiwada H
Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
